Koch Disruptive Technologies to Lead $150 Million Investment of INSIGHTEC

The medical device company is transforming neurological treatments through its non-invasive focused ultrasound applications

Koch Disruptive Technologies, a subsidiary of Koch Industries focused on finding and funding innovative and emerging companies, is the lead investor in a $150 million Series E funding round for INSIGHTEC, a commercial-stage medical device company revolutionizing surgery with MRI-guided focused ultrasound.

The investment, announced Thursday, will allow the company to further commercialize its approved indications, as well as continue research in areas such as Parkinson’s disease, Alzheimer’s disease and brain tumors, using the company’s breakthrough technology to deliver treatment in a non-invasive way. It is also the first investment for Koch Disruptive Technologies since the business group, led by KDT President Chase Koch, commenced operations in November.

Continue reading…

Share on facebook
Share
Share on twitter
Tweet
Share on linkedin
Share

More To Explore